MyD88 negatively controls hypergammaglobulinemia with autoantibody production during bacterial infection

Infection and Immunity

Volumn 76, Issue 4, 2008, Pages 1657-1667

  Woods, Anne ^a   Soulas Sprauel, Pauline ^a   Jaulhac, Benoit ^b   Arditi, Bérénice ^a   Knapp, Anne Marie ^a   Pasquali, Jean Louis ^a,b   Korganow, Anne Sophie ^a,b,c   Martin, Thierry ^a,b  

^a INSERM   (France)

^b UNIVERSITÉ DE STRASBOURG   (France)

^c HÔPITAL CIVIL   (France)

Author keywords

[No Author keywords available]

Indexed keywords

AUTOANTIBODY; IMMUNOGLOBULIN M ANTIBODY; MYELOID DIFFERENTIATION FACTOR 88; IMMUNOGLOBULIN M; INTERLEUKIN 1BETA CONVERTING ENZYME; MYD88 PROTEIN, MOUSE; UNCLASSIFIED DRUG;

ANIMAL MODEL; ANTIBODY PRODUCTION; ARTICLE; B LYMPHOCYTE; BORRELIA BURGDORFERI; BORRELIA INFECTION; CELL ACTIVATION; CELL FUNCTION; CELL TRANSFER; CONTROLLED STUDY; DENDRITIC CELL; HYPERGAMMAGLOBULINEMIA; KNOCKOUT MOUSE; MOUSE; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; PROTEIN FUNCTION; T LYMPHOCYTE; ANIMAL; CD4+ T LYMPHOCYTE; CELL CULTURE; GENE EXPRESSION REGULATION; GENETICS; IMMUNOLOGY; LYME DISEASE; LYMPHOCYTE ACTIVATION; METABOLISM; MOUSE MUTANT; PHYSIOLOGY;

ANIMALS; AUTOANTIBODIES; B-LYMPHOCYTES; BORRELIA BURGDORFERI; CASPASE 1; CD4-POSITIVE T-LYMPHOCYTES; CELLS, CULTURED; GENE EXPRESSION REGULATION; HYPERGAMMAGLOBULINEMIA; IMMUNOGLOBULIN M; LYME DISEASE; LYMPHOCYTE ACTIVATION; MICE; MICE, KNOCKOUT; MYELOID DIFFERENTIATION FACTOR 88;

EID: 42149171346     PISSN: 00199567     EISSN: None     Source Type: Journal    
DOI: 10.1128/IAI.00951-07     Document Type: Article

References (49)

1. Adachi, O., T. Kawai, K. Takeda, M. Matsumoto, H. Tsutsui, M. Sakagami, K. Nakanishi, and S. Akira. 1998. Targeted disruption of the MyD88 gene results in loss of IL-1- and IL-18-mediated function. Immunity 9:143-150.
2. Akira, S., and K. Takeda. 2004. Toll-receptor signalling. Nat. Rev. Immunol. 4:499-511.
3. Alexopoulou, L., T. Venetta, M. Schnare, Y. Lobet, J. Anguita, R. T. Schoen, R. Medzhitov, E. Fikrig, and R. A. Flavell. 2002. Hyporesponsiveness to vaccination with Borrelia burgdorferi OspA in humans and in TLR1- and TLR2-deficient mice. Nat. Med. 8:878-884.
4. Amsen, D., J. M. Blander, G. R. Lee, K. Tanigaki, T. Honjo, and R. A. Flavell. 2004. Instruction of distinct CD4 T helper cell fates by different Notch ligands on antigen presenting cells. Cell 117:515-526.
5. Banchereau, J., and R. M. Steinman. 1998. Dendritic cells and the control of immunity. Nature 392:245-252.
6. Barthold, S. W., D. S. Beck, G. H. Hansen, G. A. Terwilliger, and K. D. Moody. 1990. Lyme borreliosis in selected strains and ages of laboratory mice. J. Infect. Dis. 162:133-138.
7. Bolz, D. D., S. S. Sundsbak, Y. Ma, S. Akira, C. J. Kirshning, J. F. Zachary, J. H. Weis, and J. J. Weis. 2004. MyD88 plays a unique role in host defense but not arthritis development in Lyme disease. J. Immunol. 173:2003-2010.
8. Cobbold, S. P., G. Martin, and H. Waldmann. 1990. The induction of skin graft tolerance in major histocompatibility complex-mismatched or primed recipients: primed T cells can be tolerized in the periphery with anti-CD4 and anti-CD8 antibodies. Eur. J. Immunol. 20:2747-2755.
9. Degli-Esposti, M. Z. A., and M. J. Smyth. 2005. Close encounters of different kinds: dendritic cells and NK cells take center stage. Nature 5:112-124.
10. Donati, D., L. P. Zhang, Q. Chen, A. Chêne, K. Flick, M. Nyström, M. Wahlgren, and M. T. Bejarano. 2004. Identification of a polyclonal B-cell activator in Plasmodium falciparum. Infect. Immun. 72:5412-5418.
11. Edelson, B. T., and E. R. Unanue. 2002. MyD88-dependent but Toll-like receptor 2-independent innate immunity to Listeria: no role for either in macrophage listericidal activity. J. Immunol. 169:3869-3875.
12. Emery, P., and F. Ponchel. 2006. Inhibiting Toll-like receptors in inflammatory disease. Lancet 368:821-822.
13. Guerau-de-Arellano, M., and B. T. Huber. 2005. Chemokines and Toll-like receptors in Lyme disease pathogenesis. Trends Mol. Med. 11:114-120.
14. Hunziker, L., M. Recher, A. J. Macpherson, A Ciurea, S. Freigang, H. Hengartner, and R. M. Zinkernagel. 2003. Hypergammaglobulinemia and autoantibody induction mechanisms in viral infections. Nat. Rev. Immunol. 4:343-349.
15. Imler, J.-L., and J. A. Hoffmann. 2001. Toll receptors in innate immunity. Trends Cell Biol. 11:304-311.
16. Jaulhac, B., R. Heller, F. X. Limbach, Y. Hansmann, D. Lipsker, H. Monteil, J. Sibilia and Y. Piemont. 2000. Direct molecular typing of Borrelia burgdorferi sensu lato species in synovial samples from patients with Lyme arthritis. J. Clin. Microbiol. 38:1895-1900.
17. Jiang, H., and L. Chess. 2006. Regulation of immune responses by T cells. N. Engl. J. Med. 354:1166-1176.
18. Kaisho, T., K. Hoshino, T. Iwabe, O. Takeuchi, T. Yasui, and S. Akira. 2002. Endotoxin can induce MyD88-deficient dendritic cells to support Th2 cell differentiation. Int. Immunol. 14:695-700.
19. Kapsenberg, M. L. 2003. Dendritic-cell control of pathogen-driven T-cell polarization. Nat. Rev. Immunol. 3:984-993.
20. Koenig-Marrony, S., P. Soulas, S. Julien, A.-M. Knapp, J.-C. Garaud, T. Martin, and J.-L. Pasquali. 2001. Natural autoreactive B cells in transgenic mice reproduce an apparent paradox to the clonal tolerance theory. J. Immunol. 166:1463-1470.
21. Kouskoff, V., A. S. Korganow, V. Duchatelle, C. Degott, C. Benoist, and D. Mathis. 1996. Organ-specific disease provoked by systemic autoimmunity. Cell 87:811-822.
22. Kuida, K., A. Lippke, G. Ku, M. W. Harding, D. J. Livingston, M. S. Su, and R. A. Flavell. 1995. Altered cytokine export and apoptosis in mice deficient in interleukine-β converting enzyme. Science 267:2000- 2003.
23. Leadbetter, E. A., I. R. Rifkin, A. M. Hohlbaum, B. C. Beaudette, M. J. Shlomchik, and A. Marshak-Rothstein. 2002. Chromatin-IgG complexes activate B cells by dual engagement of IgM and Toll-like receptors. Nature 416:603-607.
24. Liu, N., R. R. Montgomery, S. W. Barthold, and L. K. Bockenstedt. 2004. Myeloid differentiation antigen 88 deficiency impairs pathogen clearance but does not alter inflammation in Borrelia burgdorferi-infected mice. Infect. Immun. 72:3195-3203.
25. Liu, N., N. Ohnishi, L. Ni, S. Akira, and K. B. Bacon. 2003. CpG directly induces T-bet expression and inhibits IgG1 and IgE switching in B cells. Nat. Immunol. 4:687-693.
26. Lutz, M. B., N. Kulutsch, A. L. Ogilvie, S. Rossner, F. Koch, N. Romai, and G. Schuler. 1999. An advanced culture method for generating large quantities of highly pure dendritic cells from mouse bone marrow. J. Immunol. Methods 223:77-92.
27. Ma, Y., and J. J. Weis. 1993. Borrelia burgdorferi outer surface lipoproteins OspA and OspB possess B-cell mitogenic and cytokine-stimulatory properties. Infect. Immun. 61:3843-3853.
28. Minoprio, P., S. Itohara, C. Heusser, S. Tonegawa, and A. Coutinho. 1989. Immunobiology of murine T. cruzi infection: the predominance of parasite-non-specific responses and the activation of TcRI T cells. Immunol. Rev. 112:183-207.
29. Monteforte, G. M., K. Takeda, M. Rodriguez-Sosa, S. Akira, J. R. David, and A. R. Satoskar. 2000. Genetically resistant mice lacking IL-18 gene develop Th1 response and control cutaneous Leishmania major infection. J. Immunol. 164:5890-5893.
30. Moser, M., and K. M. Murphy. 2000. Dendritic cell regulation of Th1-Th2 development. Nat. Immunol. 1:199-205.
31. Muraille, E., C. De Trez, M. Brait, P. De Baetselier, L. Oberdan, and Y. Carlier. 2002. Genetically resistant mice lacking MyD88-adapter protein display a high susceptibility to Leishmania major infection associated with a polarized Th2 response. J. Immunol. 170:4237-4241.
32. Murphy, K. M., and S. L. Reiner. 2000. The lineage decisions of helper T cells. Nat. Rev. Immunol. 2:933-944.
33. Ochsenbein, A. F., T. Fehr, C. Lutz, M. Suter, F. Brombacher, H. Hengartner, and R. M. Zinkernagel. 1999. Control of early viral and bacterial distribution and disease by natural antibodies. Science 286:2156-2159.
34. Pasare, C., and R. Medzhitov. 2005. Control of B-cell responses by Toll-like receptors. Nature 438:364-368.
35. Recher, M., K. S. Lang, L. Hunziker, S. Freigang, B. Eschli, N. L. Harris, A. Navarini, B. M. Senn, K. Fink, M. Löstcher, L. Hangartner, R. Zellweger, M. Hersberger, A. Theocharides, H. Hengartner, and R. M. Zinkernagel. 2004. Deliberate removal of T cell help improves virus-neutralizing antibody production. Nat. Immunol. 5:934-942.
36. Reina-San-Martin, B., W. Degrave, C. Rougeot, A. Cosson, N. Chamond, A. Cordeiro-Da-Silva, M. Arala-Chaves, A. Coutinho, and P. Minoprio. 2000. A B-cell mitogen from a pathogenic trypanosome is a eukaryotic proline racemase. Nat. Med. 6:890-897.
37. Sakaguchi, S. 2000. Regulatory T cells: key controllers of immunologic self-tolerance. Cell 101:455-458.
38. Satoskar, A. R., M. Okano, S. Connaughton, A. Raisanen-Sokolwski, J. R. David, and M. Labow. 1998. Enhanced Th2-like responses in IL-1 type 1 receptor-deficient mice. Eur. J. Immunol. 28:2066-2074.
39. Scanga, C. A., J. Aliberti, D. Jankovic, F. Tilloy, S. Bennouna, E. Y. Denkers, R. Medzhitov, and A. Sher. 2002. MyD88 is required for resistance to Toxoplasma gondii infection and regulates parasite induced IL-12 production by dendritic cells. J. Immunol. 168:5997-6001.
40. Schnare, M., G. M. Barton, A. C. Holt, K. Takeda, S. Akira, and R. Medzhitov. 2001. Toll-like receptors control activation of adaptative immune responses. Nat. Immunol. 10:947-950.
41. Silverstein, A. M., and N. R. Rose. 2003. On the implications of polyclonal B cell activation. Nat. Immunol. 4:931-932.
42. Soulas, P., A. Woods, B. Jaulhac, A. M. Knapp, J.-L. Pasquali, T. Martin, and A.-S. Korganow. 2005. Autoantigen, innate immunity, and T cells cooperate to break B cell tolerance during bacterial infection. J. Clin. Investig. 8:2257-2267.
43. Sun, D., and A. Ding. 2006. MyD88-mediated stabilization of interferon-γ-induced cytokine and chemokine mRNA. Nat. Immunol. 7:375-381.
44. Sun, J., M. Walsch, A. V. Villarino, L. Cervi, C. A. Hunter, Y. Choi, and E. J. Pearce. 2005. TLR ligands can activate dendritic cells to provide a MyD88-dependent negative signal for Th2 cell development. J. Immunol. 174:742-751.
45. Reference deleted.
46. Woods, A., F. Monneaux, P. Soulas-Sprauel, S. Muller, T. Martin, A. S. Korganow, and J. L. Pasquali. 2007. Influenza virus-induced type I interferon leads to polyclonal B-cell activation but does not break down B-cell tolerance. J. Virol. 81:12525-12534.
47. Wooten, R. M., Y. Ma, R. A. Yoder, J. P. Brown, J. H. Weis, J. F. Zachary, C. J. Kirschning, and J. J. Weis. 2002. Toll-like receptor 2 is required for innate, but not acquired host defense to Borrelia burgdorferi. J. Immunol. 168:348-355.
48. Yang, L., Y. Ma, R. Schoenfeld, M. Griffiths, E. Eichwald, B. Araneo, and J. J. Weiss. 1992. Evidence for B-lymphocyte mitogenic activity in Borrelia burgdorferi-infected mice. Infect. Immun. 60:3033-3041.
49. Yang, R., F. M. Murillo, M. J. Delannoy, R. L. Blosser, W. H. Yutzy, S. Uematsu, K. Takeda, S. Akira, R. P. Viscidi, and R. B. Roden. 2005. B lymphocyte activation by human papilloma virus-like particles directly induces Ig class switch recombination via TLR4-MyD88. J. Immunol. 174: 7912-7919.